Correct dosage and administration of elastran

Elacestrant is a new type of selective estrogen receptor modulator (SERM), mainly used to treat certain types of breast cancer, especially estrogen receptor-positive (ER+) breast cancer. It inhibits the effects of estrogen by binding to estrogen receptors, thereby slowing or stopping the growth of breast cancer cells.

The recommended dose of elastran is 345 mg once daily. It can be taken with food, but it is best avoided on an empty stomach. When taking it, patients need to follow the doctor's advice and make sure to take it on time each time. The taking of the drug is not significantly affected by diet. Therefore, patients can choose to take it after meals or other suitable time periods, as long as the regularity of once a day can be ensured. For optimal results, patients should continue taking elastran until disease progression or intolerable toxicity occurs.

The use of elastran is relatively simple, but patients should ensure that they take the medication regularly as directed by their doctor and pay close attention to their body's response during treatment. If discomfort or side effects occur, you should communicate with your doctor promptly and make appropriate adjustments. For some possible side effects, such as gastrointestinal discomfort, fatigue, or mild allergic reactions, patients should not stop taking the medication or adjust the dose on their own, but should discuss it with their doctor to find the most appropriate solution.

In addition, elastran is often used in patients who have failed or have developed resistance to conventional treatments. Especially for patients with breast cancer who are estrogen receptor-positive (ER+) and have hormone receptor resistance or resistance, elastran provides an effective treatment option. Patients need to undergo regular medical examinations during treatment to monitor drug effects and the occurrence of side effects.

References:https://www.drugs.com/mtm/elacestrant.html